The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer.
 
Eva Lengyelova
Employment - Clarity Pharmaceuticals
Leadership - Clarity Pharmaceuticals
Stock and Other Ownership Interests - Clarity Pharmaceuticals
Travel, Accommodations, Expenses - Clarity Pharmaceuticals
 
Veronica Wong
Research Funding - Clarity Pharmaceuticals
 
Nat Lenzo
Employment - GenesisCare
Stock and Other Ownership Interests - Clarity Pharmaceuticals; Telix Pharmaceuticals
Research Funding - Clarity Pharmaceuticals; Ipsen; Telix Pharmaceuticals
 
Michelle Parker
Employment - Clarity Pharmaceuticals
Leadership - Clarity Pharmaceuticals
 
Louise Emmett
Consulting or Advisory Role - Clarity Pharmaceuticals; Noxopharm
Speakers' Bureau - Astellas Pharma (Inst); Janssen Oncology; Janssen Oncology; mundipharma
Research Funding - Novartis (Inst); Novartis (Inst); Noxopharm (Inst); Noxopharm (Inst)